200 related articles for article (PubMed ID: 33077013)
1. Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials.
Zhang Q; Xu B; Lv J; Wang Z; Du J
Cardiol Young; 2020 Dec; 30(12):1882-1889. PubMed ID: 33077013
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil for pulmonary hypertension in neonates.
Kelly LE; Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005494. PubMed ID: 28777888
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.
Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA
Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil for adult Asian patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
Shi Q; Wang Z; Yang N; Ma Y; Chen Y; Wei H; Yao H
Ann Palliat Med; 2022 Jan; 11(1):339-351. PubMed ID: 35144425
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil for pulmonary hypertension in neonates.
Shah PS; Ohlsson A
Cochrane Database Syst Rev; 2011 Aug; (8):CD005494. PubMed ID: 21833954
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil for pulmonary hypertension in neonates.
Shah PS; Ohlsson A
Cochrane Database Syst Rev; 2007 Jul; (3):CD005494. PubMed ID: 17636802
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis.
Cao F; Wu K; Zhu YZ; Jiang JJ; Zhang G; Liu J; Xiao P; Tian Y; Zhang W; Zhang S; Hou F; Bao ZW
Front Cardiovasc Med; 2022; 9():1055897. PubMed ID: 36712266
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
Oliynyk OV; Rorat M; Strepetova OV; Dubrov SO; Guryanov VG; Oliynyk YV; Kulivets OS; Ślifirczyk A; Barg W
Viruses; 2023 May; 15(5):. PubMed ID: 37243243
[TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor antagonists for pulmonary arterial hypertension.
Liu C; Chen J
Cochrane Database Syst Rev; 2006 Jul; (3):CD004434. PubMed ID: 16856046
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials.
Awad AK; Gad ER; Abdelgalil MS; Elsaeidy AS; Ahmed O; Elbadawy MA
BMC Pediatr; 2023 Jul; 23(1):372. PubMed ID: 37474896
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil in Term and Premature Infants: A Systematic Review.
Perez KM; Laughon M
Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
[TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and cost-effectiveness of bosentan and sildenafil as therapeutic drugs for pediatric pulmonary arterial hypertension.
Chen T; Chen J; Chen C; Zheng H; Chen Y; Liu M; Zheng B
Pediatr Pulmonol; 2021 Jul; 56(7):2250-2258. PubMed ID: 33856119
[TBL] [Abstract][Full Text] [Related]
14. Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis.
Usmani SUR; Hasan SU; Ali SH; Ahmed SH; Pervez N; Danial M; Khan O; Tucker DL; Zubair MM
Asian J Surg; 2024 Jun; 47(6):2551-2557. PubMed ID: 38531747
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
He B; Zhang F; Li X; Tang C; Lin G; Du J; Jin H
Circ J; 2010 Jul; 74(7):1458-64. PubMed ID: 20519876
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis.
Zhou R; Zhao Z; Liu J; Liu M; Xie F
Heart Lung; 2024; 64():36-45. PubMed ID: 37992575
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
18. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension].
Sun X; Wang K; Wang W; Li B
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):414-8. PubMed ID: 25169631
[TBL] [Abstract][Full Text] [Related]
20. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
Dranitsaris G; Mehta S
Appl Health Econ Health Policy; 2009; 7(1):43-59. PubMed ID: 19558194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
